Free Trial

This company has been marked as potentially delisted and may not be actively trading.

Boundless Bio (BOLD) Earnings Date, Estimates & Call Transcripts

Boundless Bio logo

Boundless Bio Earnings Summary

Boundless Bio issued Q1 2025 earnings on May 9, 2025, reporting an EPS of -$0.71, which missed analysts' consensus estimates of -$0.68 by $0.03. With a trailing EPS of $0.00, Boundless Bio's earnings are expected to grow next year, from ($3.85) to ($3.35) per share.

Consensus EPS
(May. 9)
-$0.68
Actual EPS
(May. 9)
-$0.71 Missed By -$0.03

Q1 2025 Earnings Resources

Get Boundless Bio Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Boundless Bio and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

BOLD Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Boundless Bio Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20251-$0.66-$0.66-$0.66
Q2 20252-$0.78-$0.72-$0.75
Q3 20252-$0.78-$0.27-$0.53
Q4 20252-$0.79-$0.29-$0.54
FY 2025 7 -$3.01 -$1.94 -$2.48
Q1 20261-$0.80-$0.80-$0.80
Q2 20261-$0.81-$0.81-$0.81
Q3 20261-$0.84-$0.84-$0.84
Q4 20261-$0.86-$0.86-$0.86

Boundless Bio Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
5/9/2025Q1 2025-$0.68-$0.71 -$0.03-$0.71--
3/27/2025Q4 2024-$0.74-$0.74--$0.74--
11/7/2024--$0.76-$0.74+$0.02-$0.74--
8/12/2024Q2 2024-$0.80-$0.77+$0.03-$0.77--
5/13/2024Q1 2024-$0.65-$12.27 -$11.62-$12.27--

Boundless Bio Earnings - Frequently Asked Questions

Boundless Bio (NASDAQ:BOLD) last announced its quarterly earning data on Friday, May 9, 2025. Learn more on BOLD's earnings history.

In the previous quarter, Boundless Bio (NASDAQ:BOLD) missed the analysts' consensus estimate of ($0.68) by $0.03 with a reported earnings per share (EPS) of ($0.71). Learn more on analysts' earnings estimate vs. BOLD's actual earnings.

Boundless Bio (NASDAQ:BOLD) has a recorded net income of -$65.36 million. BOLD has generated $0.00 earnings per share over the last four quarters.

Boundless Bio's earnings are expected to grow from ($3.85) per share to ($3.35) per share in the next year.

More Earnings Resources from MarketBeat



This page (NASDAQ:BOLD) was last updated on 7/13/2025 by MarketBeat.com Staff
From Our Partners